drugset / Trial / NCT00118326

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

NCT00118326

Phase 1/2 Completed Fred Hutchinson Cancer Center
Treatment

Summary

RATIONALE: A bone marrow transplant from a brother or sister may be able to replace blood-forming cells that were destroyed by chemotherapy or radiation therapy. Colony-stimulating factors, such as G-CSF, cause the body to make blood cells. Giving G-CSF to the donor may help the body make more stem cells that can be collected for bone marrow transplant and may cause fewer side effects in the patient after the transplant. PURPOSE: This phase I/II trial is studying the side effects of donor bone marrow transplant and to see how well it works in treating young patients with cancer or a non-cancerous disease.

Timeline

Start
2003-08
Primary completion
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject filgrastim Protein / enzyme biologic Subcutaneous